Serum interleukins and urinary microglobulin in children with idiopathic nephrotic syndrome

Eastern Mediterranean Health Journal

Volumn 11, Issue 5-6, 2005, Pages 993-1002

  Rizk, M K ^a   El Nawawy, A ^b   Abdel Kareem, E ^b   Amer, E S ^a   El Gezairy, D ^b   El Shafei, A Z ^b  

^a BENHA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; EGYPT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOPATHOGENESIS; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; RELAPSE; REMISSION; URINALYSIS;

ANALYSIS OF VARIANCE; BETA 2-MICROGLOBULIN; BLOOD UREA NITROGEN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; EGYPT; FEMALE; HEMOGLOBINS; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; NEPHROTIC SYNDROME; PREDICTIVE VALUE OF TESTS; RECURRENCE; REMISSION INDUCTION; SERUM ALBUMIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTORS;

EID: 33744812995     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nash MA et al. The nephrotic syndrome. In: Edelman CM ed. Pediatric kidney disease, 2nd ed. Boston, Little Brown and Company, 1992:1247-66.
2. Bergstein JM. Conditions particularly associated with proteinuria. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics, 16th ed. Philadelphia, WB Saunders, 2000:1590-6.
3. Salcado JR et al. Nephrosis in childhood. Nephron, 1995, 71(4): 373-85.
4. Ordonez N, Rosai J. Urinary tract. In: Rosai J, ed. Ackerman's surgical pathology, 8th ed. St Louis, CV Mosby, 1996: 1059-163.
5. Gibson IW, More IA. Glomerular pathology: recent advances. Journal of pathology, 1998, 184(4):123-9.
6. Oppenheim JJ, Ruscetti FW, Faltynek C. Cytokines: complement & kinin. In: Stites DP, Stobo JD, Wells VJ, eds. Basic and clinical immunology, 8th ed. Norwalk, Connecticut, Appleton & Lange, 1994: 105-23.
7. Saxena S, Mittal A, Andal A. Pattern of interleukins in minimal-change nephrotic syndrome of childhood. Nephron, 1993, 65(1):56-61.
8. Suranyi MG et al. Elevated levels of tumour necrosis factor-αα in the nephrotic syndrome in humans. American journal of kidney disease, 1993, 21(3):251-9.
9. Ohta V et al. Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract. Clinical nephrology, 1992, 38(4):185-9.
10. Akutsu Y. [Study of correlation between urinary IL-6 level and mesangial lesion in childhood onset Ig A nephropathy]. Hokkaido igaku zasshi, 1994, 69(4): 686-96 (in Japanese).
11. Cohen JJ, Harrington JT, Madias NE. Dialysis related amyloidosis. Kidney international, 1992, 41:1416-29.
12. Ganong WF. Circulating body fluids. In: Ganong WF, ed. Review of medical physiology, 19th ed. Stamford, Connecticut, Appelton & Lange, 1999, 493-521.
13. Tesch GH et al. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. American journal of pathology, 1997, 151(1):141-50.
14. Abrass CK. Clinical spectrum and complications of the nephrotic syndrome. Journal of investigative medicine, 1997, 45(4): 143-53.
15. Janeway CA et al. T-cell mediated immunity. In: Janeway CA et al., eds. Immunobiology: the immune system in health and disease, 4th ed. New York, Elsevier Science, 1999:363-415.
16. Baud L, Ardaillou R. Tumour necrosis factor in renal injury. Mineral and electrolyte metabolism, 1995, 21:336-41.
17. Abott F et al. Interleukin-1beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney international, 1991, 40(4):597-605.
18. Gruss HJ. Molecular, structural and biological characteristics of the tumour necrosis factor ligand superfamily. International journal of clinical & laboratory research, 1996, 26(3):143-59.
19. Daniel V et al. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clinical nephrology, 1997, 47(5):289-97.
20. Dinarello CA. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism. International journal of tissue reactions, 1992, 14(2):65-75.
21. Kluth DC, Rees AJ. New approaches to modify glomerular inflammation. Journal of nephrology, 1999, 12(2):66-75.
22. Fukatsu A et al. Expression of interleukin-6 and major histocompatability complex molecules in tubular epithelial cells of diseased human kidneys. Laboratoy investigation, 1993, 69(1):58-67.
23. Hirano T. Interleukin-6 and its receptor: ten years later. International reviews of immunology, 1998, 16(3-4):249-84.
24. Fede C et al. N-acetyl-β-D-glucosaminidase and beta-2-microglobulin: prognostic markers in idiopathic nephrotic syndrome. Journal of nephrology, 1999, 12(1):51-5.
25. Caleskan S et al. Urinary N-acetyl-β-D-glucosaminidase and β-2-microglobulin excretion in primary nephrotic syndrome in children. Nephron, 1994, 74(2):401-4.